Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections

Journal of Zoo and Wildlife Medicine

Volumn 30, Issue 1, 1999, Pages 32-35

  Stamper, M Andrew ^a,c   Papich, Mark G ^a   Lewbart, Greg A ^a   May, Stuart B ^b   Plummer, Delta D ^a   Stoskopf, Michael K ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Pine Knoll Shores   (United States)

^c NEW ENGLAND AQUARIUM   (United States)

Author keywords

Caretta caretta; Ceftazidime; Loggerhead sea turtle; Pharmacokinetics

Indexed keywords

CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; RANDOMIZED CONTROLLED TRIAL; TURTLE;

ANIMALS; AREA UNDER CURVE; CEFTAZIDIME; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; TURTLES;

EID: 0033091966     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aguirre, A. A., G. H. Balazs, B. Zimmerman, and T. R. Spraker. 1994. Evaluation of Hawaiian green turtles (Chelonia mydas). J. Wildl. Dis. 30: 8-15.
2. Berkson, H. 1966. Physiological adjustment to prolonged diving in the Pacific green turtle (Chelonia mydas agassizii). Comp. Biochem. Physiol. 18: 101.
3. Bovée, K. C., and T. Joyce. 1979. Clinical evaluation of glomerular function: 24-hour creatinine clearance in dogs. J. Am. Vet. Med. Assoc. 174: 488-491.
4. Bush, M., J. M. Smeller, P. Charache, and R. Arthur. 1978. Biological half-life of gentamicin in gopher snakes. Am. J. Vet. Res. 39: 171-173.
5. Butler, P. J., W. K. Milsom, and A. J. Woakes. 1984. Respiratory cardiovascular and metabolic adjustments during steady state swimming in the green turtle, Chelonia mydas. J. Comp. Physiol. B. 154: 167.
6. Caligiuri, R., G. V. Kollias, E. Jacobson, B. McNab, G. H. Clark, and R. C. Wilson. 1990. The effects of ambient temperature on amikacin pharmacokinetics in gopher tortoises. J. Vet. Pharmacol. Ther. 13: 287-291.
7. Campbell, T. W. 1996. Sea turtle rehabilitation. In: Mader, D. R. (ed.). Reptile Medicine and Surgery. W. B. Saunders Co., Philadelphia, Pennsylvania. Pp. 427-435.
8. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York, New York.
9. Mader, D., G. Conzelman, and J. D. Baggot. 1985. Effects of ambient temperature on the half-life and dosage regimen of amikacin in the gopher snake. J. Am. Vet. Med. Assoc. 187: 1134-1136.
10. Matsui, H., M. Komiya, C. Ikeda, and A. Tachibana. 1984. Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys. Antimicrob. Agents Chemother. 26: 204-207.
11. Nichols, W. W. 1988. Towards a fundamental understanding on the MIC of β-lactam antibiotics. J. Antimicrob. Chemother. 22: 275-283.
12. Richards, D. M., and R. N. Brogen. 1985. Ceftazidime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 29: 105-161.
13. Schmidt-Nielsen, B., and L. E. Davies. 1968. Fluid transport and tubular intercellular spaces in reptilian kidneys. Science 159: 1105-1108.
14. Soriano, F. 1992. Optimal dosage of β-lactam antibiotics: time above the MIC and inoculum effect. J. Antimicrob. Chemother. 30: 566-569.
15. West, N. H., P. J. Butler, and R. M. Bevan. 1992. Pulmonary blood flow at rest and during swimming in the green turtle, Chelonia mydas. Physiol. Zool. 65: 287.
16. Westly, G., and B. Pfohl (eds.). 1994. Physician's Desk Reference. Medical Economics Data Production, Montvale, New Jersey. Pp. 1011, 1571.